華西證券(002926.SZ):預計半年度淨利潤同比增長1025.19%-1353.9%
格隆匯7月11日丨華西證券(002926.SZ)公佈,預計半年度歸屬於上市公司股東的淨利潤44,500.00萬元–57,500.00萬元,比上年同期增長1025.19%-1353.90%,扣除非經常性損益後的淨利潤43,900.00萬元–56,900.00萬元,比上年同期增長944.10%-1253.28%。
2025年上半年,公司按照特色化、差異化的發展方向,持續完善業務組織體系和商業模式,加強經營管理,積極把握市場機遇,強化合規風險管控,有效提升資產質量,推動實現上半年營業收入和歸屬於上市公司股東的淨利潤同比增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.